Viatris Study Finds Falling Antibiotic Prices Amid Rising Production Costs
Reuters
Nov 20
Viatris Study Finds Falling Antibiotic Prices Amid Rising Production Costs
Viatris Inc., in collaboration with Medicines for Europe, has published the results of an independent study analyzing the off-patent medicines market in Europe, with a particular focus on antibiotics. The study found that between 2020 and 2024, the average price of the ten most widely used off-patent antibiotics dropped by 10.4%, despite significant increases in production costs and inflation. The analysis highlights the growing challenge of ensuring patient access to essential medicines amid price pressures and supply shortages. Viatris and Medicines for Europe are urging policymakers and healthcare leaders to reform national pricing and procurement systems to safeguard the availability of vital antibiotics and strengthen sustainable access to off-patent medicines.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viatris Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: GE27432) on November 20, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.